BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Praliciguat readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Praliciguat\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07268638-940@assetmemo.bio
DTSTAMP:20261121T005646Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:Praliciguat: Phase 2 readout est. (NCT07268638)
DESCRIPTION:Praliciguat\, phase 2\, Chronic Kidney Disease.\nStudy: A Study
  of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (F
 SGS)\nEstimated primary completion: June 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/praliciguat#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT07268638
URL:https://assetmemo.bio/drug/praliciguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
